-
Product Insights
Neuropathy – Drugs In Development, 2023
Global Markets Direct’s, ‘Neuropathy - Drugs In Development, 2023’, provides an overview of the Neuropathy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Neuropathy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Sector Analysis
Menopausal Disorders (MD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Menopausal Disorders (MD) Marketed and Pipeline Drugs Report Overview Menopausal disorders are a permanent cessation of menstruation resulting in the loss of ovarian follicle development. In 2023, the highest number of prevalent cases of menopausal disorders were registered in India and China. Treatment guidelines for MD are well-established globally and at the country level and are updated periodically. For instance, in 2023, the US and China updated guidelines. In the US, guidelines were provided by the North American Menopause Society...
-
Product Insights
Ventilators Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Ventilators Pipeline Market Report Overview A ventilator is an artificial respiratory support device. It uses air pressure to deliver air into the lungs and alternatively, creates vacuum pressure to release carbon dioxide from it. The ventilators pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Carenoprazan Hydrochloride in Duodenal Ulcer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Carenoprazan Hydrochloride in Duodenal Ulcer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Carenoprazan Hydrochloride in Duodenal Ulcer Drug Details: Carenoprazan hydrochloride is a...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BMS-986360 in Sarcomas
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BMS-986360 in Sarcomas Drug Details: BMS-986360 (CC-90001) is under development for the treatment of solid...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Carenoprazan Hydrochloride in Reflux Esophagitis (Gastroesophageal Reflux Disease)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Carenoprazan Hydrochloride in Reflux Esophagitis (Gastroesophageal Reflux Disease) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Carenoprazan Hydrochloride in Reflux Esophagitis (Gastroesophageal Reflux Disease)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Carenoprazan Hydrochloride in Peptic Ulcers
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Carenoprazan Hydrochloride in Peptic Ulcers report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Carenoprazan Hydrochloride in Peptic Ulcers Drug Details:Carenoprazan hydrochloride is a new-generation candidate...